期刊文献+

急性、非急性冠状动脉病变患者血浆氧化低密度脂蛋白的变化 被引量:3

Changes of serum oxidized low-density lipoprotein in patients with acute and non-acute coronary artery disease
下载PDF
导出
摘要 目的探讨冠心病患者氧化型低密度脂蛋白(ox-LDL)的变化及机制,评估ox-LDL水平检测的临床价值。方法采用ELISA法测定139例冠心病组患者[急性冠状动脉综合征(ACS)76例,非ACS组63例]和100例健康对照组人群血浆ox-LDL水平;根据冠状动脉造影结果将冠心病组分为多支病变组、双支病变组和单支病变组进行比较分析。结果ACS组患者和非ACS组患者ox-LDL水平均显著高于健康对照组[ACS:(188.01±69.88)μg/ml,非ACS:(137.88±59.74)μg/ml,对照组:(82.68±29.06)μg/ml;P均<0.001];且ACS组患者ox-LDL水平显著高于非ACS组患者(P<0.001)。冠状动脉多支、双支、单支病变组间ox-LDL水平不同[(183.63±79.42)μg/ml,(164.15±63.79)μg/ml和(146.97±58.40)μg/ml,P<0.05],多支高于单支(P<0.01)。多因素分析显示冠状动脉病变程度仅与ox-LDL相关(R2=0.048,β=0.217,P=0.000)。结论冠心病患者ox-LDL水平升高,与病变程度相关,急性冠脉综合征患者变化尤为显著。 Objective To explore the changed mechanism of plasma oxidized low-density lipoprotein (ox-LDL) in the patients with coro- nary heart disease, and to evaluate the clinical value of detection for ox-LDL level. Methods Enzyme-linked immunosorbent assay (ELISA) was used to measure the plasma ox-LDL in 139 patients with coronary heart disease, among them 76 were acute coronary syn- drome (ACS) and 63 were non-ACS patients, and in 100 healthy controls. The patients were divided by coronary angiography into multi-vessel disease group, double-vessel disease group and mono-vessel disease group. Results The ox-LDL levels of the patients in both ACS and non-ACS groups[ (188.01±69.88)μg/ml and (137.88±59.74) μg/ml] were significantly higher than that in nor- mal controls group[ (82.68 ± 29.06 ) μg/ml ;P 〈 O. 001 ], and the ox-LDL level of patients in ACS group was significantly higher than that in non-ACS group ( P 〈0. 001 ). Different plasma levels of ox-LDL were found in the multi-vessel, double-vessel and mono-vessel disease group [ ( 183.63± 79.42) μg/ml, ( 164.15± 63.79) μg/ml, and ( 146.97 ± 58.40) μg/ml, respectively, P 〈 0.05 ]. The ox-LDL levels in multi-vessel disease group were significantly higher than that in mono-vessel group ( P 〈 0.01 ). Multiple linear re- gression analysis showed that ox-LDL levels significantly correlated with the severity of coronary artery disease ( R2 = 0. 100,13 = 0. 316 ,P =0.000). Conclusion Elevated levels of ox-LDL presented in the patients with coronary heart disease and correlated with the severity of coronary artery lesion, especially in the patients with acute coronary syndrome.
出处 《临床检验杂志》 CAS CSCD 北大核心 2009年第1期44-46,共3页 Chinese Journal of Clinical Laboratory Science
基金 国家自然科学基金资助项目(30872411)
关键词 氧化低密度脂蛋白 急性冠状动脉综合征 冠状动脉造影 oxidized low-density lipoprotein acute coronary syndrome coronary angiography
  • 相关文献

参考文献7

  • 1Fraley A E, Tsimikas S. Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease [ J ]. Curt Opin Lipid ,2006,17 (5) :502-509.
  • 2Holvoet P, Vanhaecke J, Janssens S,et al. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease [ J ]. Circulation, 1998,98 ( 15 ) : 1487-1494.
  • 3Anselmi M, Garbin U, Agostoni P, et al. Plasma levels of oxidized-low-density lipoproteins are higher in patients with unstable angina and correlated with angiographic coronary complex plaques [ J ]. Atherosclerosis,2006,185 ( 1 ) : 114-120.
  • 4O'Neill W. Issues in management of acute coronary syndromes: effects of bleeding[ J]. Clin Cardiol,2007,30( 10 Suppl 2) :II 1-3.
  • 5周助权,汪俊军,付丽,张春妮.氧化、丙二醛修饰低密度脂蛋白的ELISA检测法及临床应用[J].临床检验杂志,2007,25(6):404-406. 被引量:9
  • 6Wang J J,Zhang C N, Gong J B, et al. Development of new enzyme-linked immunosorbent assay for oxidized lipoprotein (a) by using purified human oxidized lipoprotein(a) autoantibodies as capture anti-body[ J ]. Clin Chim Acta,2007,385 ( 2 ) :73-78.
  • 7Tsimikas S, Brilakis E S, Miller E R, et al. Oxidized phospholipids, Lp (a) lipoprotein, and coronary artery disease[J]. N Engl J Med, 2005,353( 1 ) :46-57.

二级参考文献11

  • 1祝成亮,周新,刘芳,郑芳,李霞.丙二酰二醛修饰的低密度脂蛋白与冠心病的相关性研究[J].中华检验医学杂志,2005,28(7):716-718. 被引量:3
  • 2Faviou E, Vourli G, Nounopoulos C, et al. Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease[J]. Free Radic Res,2005,39(4) :419-429.
  • 3Virella G, Derrick M B, Pate V,et al. Development of capture for different modifications of human low-density lipoprotein [ J ]. Clin Diagn Lab immunol,2005,12 ( 1 ) :68-75.
  • 4Holvoet P, Stassen J M, Van Cleemput J, et al. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease [ J ]. Arterioscler Thromb Vasc Biol, 1998,18 ( 1 ) : 100-107.
  • 5Holvoet P, Perez G, Zhao Z, et al. Malondialdehyde-modified LDL in patients with atherosclerotic disease [ J ]. J Clin Invest, 1995,95 (6) : 2611-2619.
  • 6Ehara S, Ueda M, Naruko T,et al. Elevated levels of oxidized low density lipoprotein show a positive correlation with the severity of acute coronary syndromes [ J ]. Circulation, 2001,103 ( 15 ) : 1955- 1960.
  • 7Wang J J, Liu X Z, Zhuang Y Y, et al. Correlation between susceptibility of LDL subfractions to in vitro oxidation and in vivo oxidized LDL[ J]. Clin Biochem,2000,33 ( 1 ) :71-73.
  • 8Wang J J,Zhuang Y Y,Liu X Z,et al. The in vivo oxidized LDL to LDL-cholesterol ratio is correlated with lipid content of LDL [ J ]. Atherosclerosis,2000,149( 1 ) :217-218.
  • 9Hu B, Wang J J,Zhang C N, et al. Positive correlation between in vivo oxidized LDL and LDL immune complexes [ J ]. Clin Biochem, 2004,37( 1 ) :72-75.
  • 10Wang J J, Qiang H J, Zhang C N, et al. Detection of IgG bound Lp (a) immune complexes in patients with coronary heart disease [ J]. Clin Chim Acta, 2003,327 ( 1-2 ) : 113-122.

共引文献8

同被引文献39

  • 1陈玉成,梁玉佳,刘瑞,黄明慧,曾智.氧化低密度脂蛋白对血管内皮细胞骨架的损伤及其机制[J].心血管康复医学杂志,2004,13(4):320-321. 被引量:41
  • 2汪俊军,顾振华,张春妮,范乐明.脂蛋白(a)氧化和自身免疫与动脉粥样硬化的关系[J].医学研究生学报,2005,18(8):740-742. 被引量:22
  • 3孙晓宁,张昕,龚开政,曹莉霖,张振刚.氧化修饰低密度脂蛋白与冠状动脉病变严重程度的关系[J].实用心脑肺血管病杂志,2005,13(5):261-263. 被引量:1
  • 4Wang JJ, Niu DM, Meng Y, et al. Plasma oxidized lipoprotein(a) and its immune complexes are present in newborns and children[J]. Clin Chim Acta, 2009, 4071(1-2): 1-5.
  • 5Wang JJ, Zhang CN, Meng Y, et el. Elevated levels of oxidized lipnprotein (a) are associated with the presence and severity of acute coronavy syndromes[J].Clin Chim Acre, 2009 ,407 (1-2) :79-82.
  • 6Wang J J, ttu B, Kong LT, et al. Native, oxidized lipoprotein(a) and lipoprotein(a) immune complex in patients with active and inactive rheumatoid arthritis: Plasma concentrations and relationship to inflammation[ J ]. Clin Chim Acta, 2008, 390( 1-2): 67-71.
  • 7Wang JJ, Zhang CN, Gong JB, et al. Development of new enzymelinked immunosorbent assay for oxidized lipoprotein (a) by using puri- fied human oxidized lipoprotein(a) autoantibodies as capture antibody [J]. Clin Chim Acta, 2007,385(1-2) : 73-78.
  • 8Wang J J, Zhuang YY, Yao XD. Quantitation of plasminogen epitopes of seram lipoprotein(a) by sandwich enzyme linked immunosorbent assay[J]. Clin Chim Acta, 1997, 265(1): 121-130.
  • 9Yamada S, Morishita R, Nakamura S, et al. Development of antibody against epitope of lipoprotein(a) modified by oxidation: evaluation of new enzyme-linked immunosorbent assay for oxidized lipoprotein (a) [J]. Circulation, 2000, 102(14) : 1639-1644.
  • 10Podrez EA, O'Neil J, Salomon RG, et al. Measurement of oxidation in plasma Lp(a) in CAPD patients using a novel ELISA[ J ]. Kidney Int, 1998, 54(2) : 637-645.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部